US Bancorp’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-31
Closed -$1.38K 4280
2024
Q3
$1.38K Buy
+31
New +$1.14K ﹤0.01% 3854
2023
Q4
Sell
-100
Closed -$2.11K 4172
2023
Q3
$2.11K Hold
100
﹤0.01% 3645
2023
Q2
$1.59K Hold
100
﹤0.01% 3736
2023
Q1
$1.85K Hold
100
﹤0.01% 3772
2022
Q4
$2.27K Hold
100
﹤0.01% 3741
2022
Q3
$3K Hold
100
﹤0.01% 3772
2022
Q2
$4K Sell
100
-227
-69% -$7.75K ﹤0.01% 3680
2022
Q1
$18K Buy
327
+92
+39% +$5.71K ﹤0.01% 3146
2021
Q4
$15K Buy
235
+79
+51% +$7.67K ﹤0.01% 3280
2021
Q3
$22K Buy
156
+2
+1% +$255 ﹤0.01% 3095
2021
Q2
$20K Buy
154
+36
+31% +$4.49K ﹤0.01% 3148
2021
Q1
$20K Buy
118
+50
+74% +$10.5K ﹤0.01% 3034
2020
Q4
$14K Buy
68
+18
+36% +$3.48K ﹤0.01% 3066
2020
Q3
$10K Buy
50
+13
+35% +$2.91K ﹤0.01% 3094
2020
Q2
$10K Buy
37
+4
+12% +$1.07K ﹤0.01% 3113
2020
Q1
$9K Buy
+33
New +$10.1K ﹤0.01% 3071

Other funds holding QTTB

US Bancorp's QTTB Position: Q4 2024 in Review

US Bancorp sold out of Q32 Bio (QTTB) in Q4 2024, closing a stake of 31 shares — an estimated $1.38K sold.

US Bancorp first reported a position in QTTB in Q1 2020 and held it in 16 quarters. The position peaked at $22K in Q3 2021. 92 funds tracked by Wall St. Rank hold QTTB as of Q4 2024.

  • US Bancorp reported no remaining Q32 Bio position as of Q4 2024 after selling out during the quarter.
  • US Bancorp sold 31 Q32 Bio shares in Q4 2024, an estimated $1.38K.
  • US Bancorp first reported a position in Q32 Bio in Q1 2020 and held it in 16 quarters.
  • US Bancorp's Q32 Bio position peaked at $22K in Q3 2021.
  • 92 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2024.

Based on US Bancorp's 13F filing for Q4 2024, filed 5 Feb 2025.